查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1828092

2025年全球自动输血设备市场报告

Autotransfusion Devices Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，自动输血设备的市场规模稳定成长，预计2024年将达到12.1亿美元，2025年将达到12.6亿美元，复合年增长率为4.4%。预测期内的增长可归因于多种因素，例如外科手术的增加、心血管疾病、整形外科手术和关节关节重建手术的日益流行、对患者安全的日益重视以及降低输血成本的努力。

预计未来几年自动输血设备市场规模将强劲成长，2029年将达到16.7亿美元，复合年增长率为7.2%。预测期内的增长归因于老年人口的增长、门诊手术中心的扩张、产科对血液保护的重视以及新兴医疗保健市场的普及。预测期内的主要趋势包括血液处理技术的进步、先进感测器的整合、各种手术的客製化、单一供体闭合迴路系统以及设备小型化。

自体输血装置是一种用于在医疗操作过程中抽取并重新输注患者自身血液的工具，该过程称为自体输血。这种方法显着减少了对异体输血的需求。这类装置广泛应用于急诊和外科创伤护理。

自动输血设备的关键组件包括自体输血系统、耗材和配件。自体输血系统涵盖医疗设备和方法，使患者能够接收自身血液进行输血，无需外部供血。它们用于各种医疗应用，包括心血管、整形外科、神经科、产科和妇科手术，并满足各种最终用户的需求，包括医院、专科诊所和其他医疗机构。

2025年春季美国关税的突然上调及其引发的贸易摩擦对医疗设备行业产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价，製造商面临利润压力。监管挑战使情况更加复杂，因为由于关税而更换供应商通常需要医疗设备重新认证，导致市场进入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司（The Business Research Company）新报告系列的一部分，该系列提供自动输血设备光学元件市场统计数据，包括全球市场规模、区域份额、竞争对手的自动输血设备光学元件市场份额、详细的自动输血设备光学元件细分市场、市场趋势和机会，以及在自动输血设备光学元件行业取得成功所需的数据。本自动输血设备光学元件市场研究报告对该行业的现状和未来趋势进行了详细分析，为您提供所需的一切资讯的完整观点。

未来五年7.2%的预测成长率，较我们先前对该市场的预测略有下降0.2%。这一下降主要源自于美国与其他国家之间关税的影响。这种影响可能会直接影响美国，例如对英国血液回收过滤器和以色列离心机转鼓系统的进口限制，从而增加术中血液回收的成本。此外，由于贸易紧张局势和限制加剧，互惠关税以及全球经济和贸易的负面影响也将对美国产生更广泛的影响。

心血管疾病 (CVD) 的预期成长将推动自体输血设备市场的成长。 CVD 会损害心臟和血管，在减少对异体输血的依赖方面发挥关键作用。这些设备有助于患者重新输入自身血液，从而降低与捐赠者输血相关的风险。值得注意的是，美国心臟协会 ( 美国 Heart Association) 的《心臟病和中风统计数据 - 2022 年更新》报告强调，CVD 是全球主要死亡原因，每年约夺走 1790 万人的生命，这突显了市场的发展轨迹。

日益增长的血液保护需求预计将成为自体输血设备市场的主要驱动力。在外科手术中，血液保护旨在避免术中和术后异体输血，从而改善患者预后并保护患者健康。自体输血设备可有效减少外科手术的出血，有助于改善病患復健。根据世界卫生组织 (WHO) 2023 年 6 月发布的报告，73% 的报告国家（171 个国家中的 125 个）已实施国家血液政策。这表明血液保护措施已被广泛采用，并证实了市场的成长。

预计整形外科手术的兴起将推动自体输血设备市场的成长。整形外科手术包括解决与肌肉骨骼系统相关问题的医疗程序，包括骨骼、关节、韧带、肌腱和肌肉。此类手术的增加与治疗损伤和退化性疾病的需求不断增长以及老龄化人口需要关节置换和修復有关。自体输血设备在整形外科手术中发挥着至关重要的作用，它透过收集、处理和回输患者在手术中流失的血液，减少了对捐血的需求，并最大限度地降低了输血相关併发症的风险。例如，根据英国整形外科协会的一份报告，2022 年 5 月，英格兰 3 月进行了超过 42,000 例整形外科手术，这是自 2021 年 6 月以来的最高数字。因此，整形外科手术频率的增加正在推动自体输血设备的需求。

自动输血设备市场的主要企业致力于打造技术先进的解决方案，包括旨在提高输血准确性、效率和患者预后的下一代智慧控制软体。这款新一代软体利用复杂的演算法即时优化血液采集、处理和回输，进而提高效率和病人安全性。例如，2023年3月，美国血液和血浆供应及服务公司Haemonetics Corporation宣布，其Cell Saver Elite+自体输血系统已获得美国食品药物管理局（FDA）的批准。这款新一代软体可在预计会出现中度至重度失血的外科手术过程中最大限度地提高红血球的回收率。这项创新升级简化了自体输血流程，最大限度地减少了不必要的异体输血，并最终改善了患者的预后。

产品开发创新，尤其是下一代智慧控制软体的集成，已被证明是领先的自动输血设备製造商关注的重点。此次名为「智慧控制」的软体升级引入了多项重大改进，旨在简化操作，从而提升效率和用户体验。例如，2023年3月，美国医疗保健公司Haemonetics的下一代智慧控制软体获得了FDA 510(k)批准，该软体专为其Cell Saver Elite+自动输血系统设计。这项软体技术的进步再次印证了Haemonetics致力于开发开创性解决方案的承诺，旨在改善涉及中度至重度失血情况的手术中的患者预后，涵盖心臟、整形外科、创伤、移植、血管和妇科手术。

自动输血设备市场的主要企业包括 Becton Dickinson and Company、Medtronic plc、LivaNova plc、Haemonetics Corporation、Fresenius SE & Co KGaA、Terumo Corporation、Asahi Kasei Medical Co.Ltd.、B. Braun Melsungen AG、GE HealthCare Technologies Inc.、Ceei Medical Co.Ltd.. AB、北京中科思凯科技有限公司、Braille Biomedica、Redax SpA、Teleflex Incorporated、Zimmer Biomet Holdings Inc.、Gen World Medical Devices Corporation、Soma Technology International LLC、北京晶晶医疗器材有限公司、强生公司、Sorin Group、百特国际公司、Dideco 和 Nipro Corporation。

2024年自动输血设备市场最大的地区是北美。预计预测期内，亚太地区将成为全球自动输血设备市场成长最快的地区。自动输血设备市场报告涵盖的地区包括亚太地区、西欧、中欧和东欧、北美、南美以及中东和非洲。

自动输血设备市场报告涵盖的国家：澳洲、巴西、中国、法国、德国、印度、印尼、日本、俄罗斯、韩国、英国、美国、加拿大、义大利、西班牙

自动输血设备市场包括体外循环输液设备和非体外循环输液设备的销售。该市场的价值指的是“出厂价”，即产品製造商或生产商销售给其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接销售给最终客户的价值。该市场的产品价值还包括产品製造商提供的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球自动输血设备：PESTEL 分析（政治、社会、科技、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球自动输血设备市场：成长率分析
  • 全球自动输血设备市场表现：规模与成长，2019-2024
  • 全球自动输血设备市场预测：规模与成长，2024-2029年，2034年
  • 全球自动输血设备：总目标市场（TAM）

第六章 市场细分

  • 全球自动输血设备市场（按产品类型、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 自体输血系统
  • 耗材及配件
  • 全球自动输血设备市场应用、效能及预测（2019-2024、2024-2029、2034）
  • 心血管外科
  • 整形外科手术
  • 神经外科
  • 妇科手术
  • 其他的
  • 全球自动输血设备市场最终用途、效能及预测（2019-2024、2024-2029、2034）
  • 专科诊所
  • 其他的
  • 全球自体输血设备市场：自体输血系统细分、类型、效能与预测（2019-2024 年、2024-2029 年、2034 年）
  • 手术自体输血系统
  • 紧急自体输血系统
  • 常规流量自体输血系统
  • 全球自动输血设备市场：耗材及配件细分、按类型、实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 恢復储层
  • 血液过滤器
  • 管组
  • 泵浦
  • 抗凝血剂

第七章 区域和国家分析

  • 全球自动输血设备市场：依地区、绩效及预测，2019-2024年、2024-2029年、2034年
  • 全球自动输血设备市场：依国家、绩效及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章：西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章：俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 自动输血设备市场：竞争格局
  • 自动输血设备市场：公司简介
    • Becton Dickinson And Company
    • Medtronic plc
    • LivaNova plc
    • Haemonetics Corporation
    • Fresenius SE & Co KGaA

第31章：其他领先和创新企业

  • Terumo Corporation
  • Asahi Kasei Medical Co. Ltd.
  • B. Braun Melsungen AG
  • GE HealthCare Technologies Inc.
  • Cerus Corporation
  • Stryker Corporation
  • Atrium Medical Technologies
  • Brightwake Ltd.
  • Getinge AB
  • Beijing ZKSK Technology Co. Ltd.
  • Braile Biomedica
  • Redax SpA
  • Teleflex Incorporated
  • Zimmer Biomet Holdings Inc.
  • Gen World Medical Devices Corporation

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第35章：市场潜力大的国家与策略

  • 2029年自动输血设备市场：提供新机会的国家
  • 2029年自动输血设备市场：细分市场将带来新机会
  • 2029年自动输血设备市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r23948u

Autotransfusion devices are tools utilized to collect and reintroduce a patient's own blood during medical procedures, reducing reliance on donated blood-a method known as autologous blood transfusion. This approach notably diminishes the necessity for allogeneic (from a separate donor) blood transfusions. These devices find widespread application in trauma care within emergency departments and surgical settings.

The primary components of autotransfusion devices encompass autotransfusion systems, consumables, and accompanying accessories. Autotransfusion systems encompass both medical devices and methodologies enabling patients to receive their own blood for transfusions, negating the need for external donor blood. They serve diverse medical applications such as cardiovascular, orthopedic, neurological, obstetrics, gynecology surgeries, among others, and cater to various end-users including hospitals, specialized clinics, and other medical facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The autotransfusion devices market research report is one of a series of new reports from The Business Research Company that provides autotransfusion devices optical components market statistics, including autotransfusion devices optical components industry global market size, regional shares, competitors with a autotransfusion devices optical components market share, detailed autotransfusion devices optical components market segments, market trends and opportunities, and any further data you may need to thrive in the autotransfusion devices optical components industry. This autotransfusion devices optical components market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The autotransfusion devices market size has grown steadily in recent years. It will grow from $1.21 billion in 2024 to $1.26 billion in 2025 at a compound annual growth rate (CAGR) of 4.4%. The growth in the historic period can be attributed to an increase in surgical procedures, cardiovascular disease prevalence, orthopedic surgeries and joint replacements, focus on patient safety, and efforts to reduce blood transfusion costs.

The autotransfusion devices market size is expected to see strong growth in the next few years. It will grow to $1.67 billion in 2029 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to the growing geriatric population, expansion of ambulatory surgical centers, focus on blood conservation in obstetrics, and adoption in developing healthcare markets. Major trends in the forecast period include technological advancements in blood processing, integration of advanced sensors, customization for different procedures, single-donor closed-loop systems, and miniaturization of devices.

The forecast of 7.2% growth over the next five years indicates a slight reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through restricted imports of blood salvage filters from the UK and centrifugal bowl systems from Israel, increasing costs for intraoperative blood recovery.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The anticipated rise in cardiovascular diseases (CVDs) is set to propel growth within the autotransfusion device market. CVDs encompass a spectrum of heart and blood vessel disorders, and autotransfusion devices play a crucial role in reducing reliance on allogeneic blood transfusions. These devices facilitate reinfusion of a patient's own blood, mitigating the risks associated with donor blood transfusions. Notably, the American Heart Association's Heart Disease and Stroke Statistics-2022 Update report highlighted CVDs as the foremost global cause of mortality, claiming approximately 17.9 million lives annually, underscoring the market's trajectory.

The escalating demand for blood conservation is expected to be a significant driver for the autotransfusion devices market. Within surgical contexts, blood conservation aims to avoid allogeneic blood transfusions during and post-surgery to enhance patient outcomes and safeguard their well-being. Autotransfusion devices effectively minimize blood loss during surgical procedures, contributing to improved patient recovery. As per the June 2023 report by the World Health Organization, a substantial percentage of reporting countries, accounting for 73% or 125 out of 171, have implemented national blood policies. This indicates a widespread initiative toward blood conservation, affirming the market's growth.

The rising number of orthopedic surgeries is anticipated to fuel the growth of the autotransfusion devices market. Orthopedic surgeries involve medical procedures that address issues related to the musculoskeletal system, which includes bones, joints, ligaments, tendons, and muscles. The increase in these surgeries can be linked to a growing demand for treatments for injuries and degenerative conditions, as well as an aging population that requires joint replacements and repairs. Autotransfusion devices play a crucial role in orthopedic surgeries by collecting, processing, and reinfusing a patient's blood lost during the operation, thereby reducing the need for donor blood and minimizing the risk of transfusion-related complications. For example, the British Orthopaedic Association reported that in May 2022, England experienced over 42,000 orthopedic surgeries in March 2022, marking the highest number since June 2021. Consequently, the rising frequency of orthopedic surgeries is driving demand for autotransfusion devices.

Leading companies in the autotransfusion devices market are concentrating on creating technologically advanced solutions, including next-generation intelligent control software designed to improve precision, efficiency, and patient outcomes during blood transfusions. This next-generation software utilizes sophisticated algorithms to optimize the recovery, processing, and reinfusion of blood in real time, thereby enhancing both efficiency and patient safety. For example, in March 2023, Haemonetics Corporation, a U.S.-based provider of blood and plasma supplies and services, announced that the Cell Saver Elite+ Autotransfusion System received clearance from the U.S. Food and Drug Administration (FDA). This next-generation software maximizes the recovery of red blood cells during surgical procedures where medium to high blood loss is anticipated. This innovative upgrade streamlines autotransfusion processes, minimizes unnecessary allogeneic transfusions, and ultimately leads to improved patient outcomes.

Innovations in product development, particularly the integration of next-generation intelligent control software, signify a pivotal focus among major autotransfusion device companies. This software upgrade, known as Intelligent Control, introduces significant enhancements aimed at simplifying operations, thereby enhancing efficiency and user experience. For instance, Haemonetics, a US-based healthcare company, received FDA 510(k) clearance for its next-generation Intelligent Control software in March 2023, specifically designed for the Cell Saver Elite+ autotransfusion system. This advancement in software technology reaffirms Haemonetics' commitment to pioneering solutions for improved patient outcomes in surgeries involving medium to high blood loss scenarios, spanning cardiac, orthopedic, trauma, transplant, vascular, and OBGYN surgeries.

Major companies operating in the autotransfusion devices market include Becton Dickinson And Company, Medtronic plc, LivaNova plc, Haemonetics Corporation, Fresenius SE & Co KGaA, Terumo Corporation, Asahi Kasei Medical Co. Ltd., B. Braun Melsungen AG, GE HealthCare Technologies Inc., Cerus Corporation, Stryker Corporation, Atrium Medical Technologies, Brightwake Ltd., Getinge AB, Beijing ZKSK Technology Co. Ltd., Braile Biomedica, Redax S.p.A., Teleflex Incorporated, Zimmer Biomet Holdings Inc., Gen World Medical Devices Corporation, Soma Technology International LLC, Beijing Jingjing Medical Equipment Co. Ltd., Johnson & Johnson Inc., Sorin Group, Baxter International Inc., Dideco, Nipro Corporation

North America was the largest region in the autotransfusion devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global autotransfusion devices market during the forecast period. The regions covered in the autotransfusion devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the autotransfusion devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The autotransfusion devices market consists of sales of on-pump transfusion devices and off-pump transfusion devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Autotransfusion Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on autotransfusion devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for autotransfusion devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The autotransfusion devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Autotransfusion Systems; Consumables And Accessories
  • 2) By Application: Cardiovascular Surgeries; Orthopedic Surgeries; Neurological Surgeries; Obstetrics And Gynecology Surgeries; Other Applications
  • 3) By End-Use: Hospitals; Specialty Clinics; Other End Users
  • Subsegments:
  • 1) By Autotransfusion Systems: Surgical Autotransfusion Systems; Emergency Autotransfusion Systems; Continuous Flow Autotransfusion Systems
  • 2) By Consumables And Accessories: Collection Reservoirs; Blood Filters; Tubing Sets; Pumps; Anticoagulants
  • Companies Mentioned: Becton Dickinson And Company; Medtronic plc; LivaNova plc; Haemonetics Corporation; Fresenius SE & Co KGaA; Terumo Corporation; Asahi Kasei Medical Co. Ltd.; B. Braun Melsungen AG; GE HealthCare Technologies Inc.; Cerus Corporation; Stryker Corporation; Atrium Medical Technologies; Brightwake Ltd.; Getinge AB; Beijing ZKSK Technology Co. Ltd.; Braile Biomedica; Redax S.p.A.; Teleflex Incorporated; Zimmer Biomet Holdings Inc.; Gen World Medical Devices Corporation; Soma Technology International LLC; Beijing Jingjing Medical Equipment Co. Ltd.; Johnson & Johnson Inc.; Sorin Group; Baxter International Inc.; Dideco; Nipro Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Autotransfusion Devices Market Characteristics

3. Autotransfusion Devices Market Trends And Strategies

4. Autotransfusion Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Autotransfusion Devices Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Autotransfusion Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Autotransfusion Devices Market Growth Rate Analysis
  • 5.4. Global Autotransfusion Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Autotransfusion Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Autotransfusion Devices Total Addressable Market (TAM)

6. Autotransfusion Devices Market Segmentation

  • 6.1. Global Autotransfusion Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Autotransfusion Systems
  • Consumables And Accessories
  • 6.2. Global Autotransfusion Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cardiovascular Surgeries
  • Orthopedic Surgeries
  • Neurological Surgeries
  • Obstetrics And Gynecology Surgeries
  • Other Applications
  • 6.3. Global Autotransfusion Devices Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Specialty Clinics
  • Other End Users
  • 6.4. Global Autotransfusion Devices Market, Sub-Segmentation Of Autotransfusion Systems, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Surgical Autotransfusion Systems
  • Emergency Autotransfusion Systems
  • Continuous Flow Autotransfusion Systems
  • 6.5. Global Autotransfusion Devices Market, Sub-Segmentation Of Consumables And Accessories, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Collection Reservoirs
  • Blood Filters
  • Tubing Sets
  • Pumps
  • Anticoagulants

7. Autotransfusion Devices Market Regional And Country Analysis

  • 7.1. Global Autotransfusion Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Autotransfusion Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Autotransfusion Devices Market

  • 8.1. Asia-Pacific Autotransfusion Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Autotransfusion Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Autotransfusion Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Autotransfusion Devices Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Autotransfusion Devices Market

  • 9.1. China Autotransfusion Devices Market Overview
  • 9.2. China Autotransfusion Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Autotransfusion Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Autotransfusion Devices Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Autotransfusion Devices Market

  • 10.1. India Autotransfusion Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Autotransfusion Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Autotransfusion Devices Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Autotransfusion Devices Market

  • 11.1. Japan Autotransfusion Devices Market Overview
  • 11.2. Japan Autotransfusion Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Autotransfusion Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Autotransfusion Devices Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Autotransfusion Devices Market

  • 12.1. Australia Autotransfusion Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Autotransfusion Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Autotransfusion Devices Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Autotransfusion Devices Market

  • 13.1. Indonesia Autotransfusion Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Autotransfusion Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Autotransfusion Devices Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Autotransfusion Devices Market

  • 14.1. South Korea Autotransfusion Devices Market Overview
  • 14.2. South Korea Autotransfusion Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Autotransfusion Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Autotransfusion Devices Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Autotransfusion Devices Market

  • 15.1. Western Europe Autotransfusion Devices Market Overview
  • 15.2. Western Europe Autotransfusion Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Autotransfusion Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Autotransfusion Devices Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Autotransfusion Devices Market

  • 16.1. UK Autotransfusion Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Autotransfusion Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Autotransfusion Devices Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Autotransfusion Devices Market

  • 17.1. Germany Autotransfusion Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Autotransfusion Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Autotransfusion Devices Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Autotransfusion Devices Market

  • 18.1. France Autotransfusion Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Autotransfusion Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Autotransfusion Devices Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Autotransfusion Devices Market

  • 19.1. Italy Autotransfusion Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Autotransfusion Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Autotransfusion Devices Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Autotransfusion Devices Market

  • 20.1. Spain Autotransfusion Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Autotransfusion Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Autotransfusion Devices Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Autotransfusion Devices Market

  • 21.1. Eastern Europe Autotransfusion Devices Market Overview
  • 21.2. Eastern Europe Autotransfusion Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Autotransfusion Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Autotransfusion Devices Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Autotransfusion Devices Market

  • 22.1. Russia Autotransfusion Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Autotransfusion Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Autotransfusion Devices Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Autotransfusion Devices Market

  • 23.1. North America Autotransfusion Devices Market Overview
  • 23.2. North America Autotransfusion Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Autotransfusion Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Autotransfusion Devices Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Autotransfusion Devices Market

  • 24.1. USA Autotransfusion Devices Market Overview
  • 24.2. USA Autotransfusion Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Autotransfusion Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Autotransfusion Devices Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Autotransfusion Devices Market

  • 25.1. Canada Autotransfusion Devices Market Overview
  • 25.2. Canada Autotransfusion Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Autotransfusion Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Autotransfusion Devices Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Autotransfusion Devices Market

  • 26.1. South America Autotransfusion Devices Market Overview
  • 26.2. South America Autotransfusion Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Autotransfusion Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Autotransfusion Devices Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Autotransfusion Devices Market

  • 27.1. Brazil Autotransfusion Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Autotransfusion Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Autotransfusion Devices Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Autotransfusion Devices Market

  • 28.1. Middle East Autotransfusion Devices Market Overview
  • 28.2. Middle East Autotransfusion Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Autotransfusion Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Autotransfusion Devices Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Autotransfusion Devices Market

  • 29.1. Africa Autotransfusion Devices Market Overview
  • 29.2. Africa Autotransfusion Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Autotransfusion Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Autotransfusion Devices Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Autotransfusion Devices Market Competitive Landscape And Company Profiles

  • 30.1. Autotransfusion Devices Market Competitive Landscape
  • 30.2. Autotransfusion Devices Market Company Profiles
    • 30.2.1. Becton Dickinson And Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. LivaNova plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Haemonetics Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Fresenius SE & Co KGaA Overview, Products and Services, Strategy and Financial Analysis

31. Autotransfusion Devices Market Other Major And Innovative Companies

  • 31.1. Terumo Corporation
  • 31.2. Asahi Kasei Medical Co. Ltd.
  • 31.3. B. Braun Melsungen AG
  • 31.4. GE HealthCare Technologies Inc.
  • 31.5. Cerus Corporation
  • 31.6. Stryker Corporation
  • 31.7. Atrium Medical Technologies
  • 31.8. Brightwake Ltd.
  • 31.9. Getinge AB
  • 31.10. Beijing ZKSK Technology Co. Ltd.
  • 31.11. Braile Biomedica
  • 31.12. Redax S.p.A.
  • 31.13. Teleflex Incorporated
  • 31.14. Zimmer Biomet Holdings Inc.
  • 31.15. Gen World Medical Devices Corporation

32. Global Autotransfusion Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Autotransfusion Devices Market

34. Recent Developments In The Autotransfusion Devices Market

35. Autotransfusion Devices Market High Potential Countries, Segments and Strategies

  • 35.1 Autotransfusion Devices Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Autotransfusion Devices Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Autotransfusion Devices Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer